Lecture: Primary Hemostasis Flashcards
Complex physiologic process that keeps circulating blood in a fluid state
Hemostasis
Systems of Hemostasis
Vasculature
Platelets
Clot Formation
Fibrinolytic
Characteristics of blood vessels
Vessels should be intact, integrity, flexible and elastic so that
blood can easily flow
It is activated by desquamation and small injuries to blood vessels; rapid, short-lived response; involves tunica intima and platelets
Primary Hemostasis
It is activated by large injuries to blood vessels and surrounding tissues; delayed, long-term response; involves platelets and coagulation factors
Secondary Hemostasis
During damaged vessel or low blood pressure, blood vessels constrict or dilate?
Constrict
During high blood pressure, blood vessels constrict or dilate?
Dilate
Innermost layer; Separates or give the barrier from platelets to the subendothelium containing collagen; Source of VWF
Tunica Intima
Middle layer; Smooth muscle and connective tissue are found
Tunica Media
Outermost layer; Makes your blood vessels intact, flexible and elastic; Connective tissue and collagen are present
Tunica Adventitia
inhibits platelet activation and
aggregation
Nitric oxide
Mediator (enhancer) of platelet
aggregation
Thromboxane
Prevents platelet aggregation; Derived from phospholipid layer of endothelial cells
Prostacyclin
Naturally-occurring anticoagulant; heparin inhibits thrombin
Heparan sulfate
Counteract thrombin by absorbing
thrombin
Thrombomodulin
Exposure of collagen results to what process?
Platelet activation
Monitor vessel linings for small holes or gaps, platelets plug holes without activation of coagulation system
Passive Surveillance
Blood vessels contract to seal the
wound or reduce the blood flow
Vasoconstriction
Refers to the role of blood vessels and platelets in the initial response to a vascular injury or to the commonplace
desquamation of dying or damaged endothelial cells.
Primary Hemostasis
VWF binds platelets through their _ membrane receptor
Gp Ib/IX/V
Major interaction is the binding of platelet receptor glycoprotein Ib/IX/V to VWF, which binds to _
Collagen
VWF is stored in _ in platelets and _ in endothelial cells.
α-granules
Weibel-Palade bodies
VWF Receptor Sites
Gp Ib/IX/V
Gp IIb/IIIa
Collagen
Factor VIII
Collagen, adenosine diphosphate (ADP), thrombin, epinephrine, thromboxane A2, arachidonic acid are all examples of?
Platelet agonists
Large surface available for biochemical reactions in secondary hemostasis
Phospholipid orientation
Gp IIb/IX/V on surface increase in number of Gp IIb/IIIa receptors on surface
Receptor expression
Loose aggregation, reversible if stimulus is not sufficient
Primary Platelet Aggregation
Irreversible provided sufficient stimulus; occurs after internal ADP release, TXA2 synthesis and
release, further stimulation
Secondary Platelet Aggregation
Factor V, VWF, Factor VIII, and fibrinogen are all example of?
Procoagulants
Substance for contact activation of intrinsic coagulation pathway
HMWK - High Molecular Weight Kininogen
Substance that is converted into fibrin for clot formation
Fibrinogen
Cofactor in fibrin clot formation
Factor V
Assists platelet adhesion to subendothelium to provide coagulation surface
Factor VIII: vWF
Dense granule substances that promote aggregation
ADP
Calcium
Alpha granule substances that promote aggregation
PF4
Thrombospondin
Dense granule substance that promotes vasoconstriction at site of injury
Serotonin
Membrane phospholipid progenitor that promotes vasoconstriction at site of injury
TxA2 Precursors
Promotes smooth muscle cell growth for vessel repair
PDGF
Chemotactic for fibroblasts to help in vessel repair
Beta-thromboglobulin
Precursor to plasmin which induces clot lysis
Plasminogen
Major inhibitor of plasmin; inhibits clot lysis
Alpha 2-antiplasmin
Complement system inhibitor
C1 esterase inhibitor
Regulates fibrin formation via protein C pathway
Protein S
Regulates fibrin formation by inhibiting tissue factor complex
TFPI (Tissue factor pathway inhibitor)
Negative regulator of platelet activation; inhibits protein kinase which inhibits aggregation
CAMP
Inhibitor of fibrinolysis
PAI-1 (Plasminogen activator inhibitor 10